To tell whether a stock is overvalued or undervalued, compare what you pay for it with what the business earns, how fast it grows and how much debt it carries. IndexAlpha's stock research workflow runs the same multi-factor analysis professional research desks use — financial health, growth, valuation, and dividend quality — on any publicly traded equity. Every score is auditable: the underlying metrics, sector comparables, and methodology are visible alongside the result.
stock research is the process of figuring out whether a company is a good investment before you buy its shares. It means looking at how profitable, stable, fairly priced, and well-managed the company is. On IndexAlpha, stock research shows up as four plain-English scores plus the key numbers that drove each score. The SEC's Investor.gov recommends beginners always research a company before buying its stock, and that's exactly what this tool is built to help with.
Type the company name or ticker symbol (like AAPL for Apple or MSFT for Microsoft) into the search bar. IndexAlpha looks up the stock across 8 major global exchanges and pulls the latest data in under 3 seconds.
The top of the report tells you — in one paragraph — whether the stock looks strong, average, or weak right now, and why. You don't have to parse numbers; the summary does that work for you.
Expand any of the four score cards (financial health, growth, valuation, dividends) to see the exact numbers. Each metric has a tooltip that explains what it means in plain English.
Compare what you pay with what the business earns and how fast it grows. A price-to-earnings ratio well above the company's own sector peers, without the growth to justify it, is the usual warning sign. IndexAlpha's valuation score makes that comparison against sector comparables rather than in isolation, and shows every number it used.
IndexAlpha looks at four independent areas — financial health, growth, valuation, and dividend quality — and combines them into one summary signal. Each area uses the numbers directly from the company's quarterly and annual filings with the SEC EDGAR system (for US-listed stocks) or the equivalent regulatory filings for international stocks.
Stock research spans the US and international markets — US exchanges (NYSE, NASDAQ), UK (London Stock Exchange), Australia (ASX), Japan (Tokyo Stock Exchange), Hong Kong (HKEX), Singapore (SGX), and Canada (Toronto Stock Exchange). If a company is publicly traded on a major exchange, you can research it here.
Stock research is free — there is no allowance to evaluate and no card to enter. Portfolio risk analysis and the research assistant are free to use as well. The paid plans are for having that work run FOR you rather than on request. Full details, and what each plan covers, are on the pricing page.
Prices update during market hours. Company fundamentals update within 24 hours of each quarterly earnings release. Multi-factor scoring recalculates daily before US market open.
No. IndexAlpha is a research and analysis platform — every output is auditable analytical work product, not a personalized recommendation. The underlying methodology, inputs, and assumptions are visible. Investment decisions remain yours. See the SEC's guide to risk tolerance for context.
Bloomberg Terminal, FactSet, and Refinitiv are built for institutional desks — market-makers, sell-side analysts, and fund managers — with five-figure annual subscriptions per seat. IndexAlpha delivers the analytical depth individual investors actually need — multi-factor stock scoring, valuation bands, sector comparables, dividend coverage — on a workstation tuned for individual decision-making, drawing on the same regulatory filings (SEC EDGAR for US equities and equivalents abroad) the professional desks use.
Beginners: If you're new to investing, start by running one or two stocks you already know (like a company whose product you use every day). The scores and summary will give you a fast read on whether it looks like a solid business. See Investor.gov's guide to stocks for background.
Intermediate investors: If you already have a portfolio, use Stock Research as a second opinion before adding a new holding. The combined score surfaces financial health and valuation red flags that are easy to miss when you're reading earnings calls on your own.